First human test of Parkinson's drug PDM608 begins
NCT ID NCT05950906
First seen Nov 18, 2025 · Last updated Apr 30, 2026 · Updated 21 times
Summary
This early-stage study tested the safety of a new drug called PDM608 in 64 healthy adults. The goal was to see if the drug is safe and how the body processes it. This is a first step before testing the drug in people with Parkinson's disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Quotient Sciences-Miami, Inc
Miami, Florida, 33126, United States
Conditions
Explore the condition pages connected to this study.